Skip to content
10-Q

Quarterly Report

ACHILLION PHARMACEUTICALS INC

0001564590-19-041721

← back to feed
Filed
Nov 7, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Nov 1, 2019 140.05M sh
Capex Q3 2019 · Sep 30, 2019 $177K
Capex Q3 2019 · Sep 30, 2018 $468K
Operating Cash Flow Q3 2019 · Sep 30, 2019 −$48.27M
Operating Cash Flow Q3 2019 · Sep 30, 2018 −$50.31M
Cash And Equivalents Q3 2019 · Sep 30, 2019 $43.57M
Cash And Equivalents Q3 2019 · Dec 31, 2018 $49.83M
Stockholders Equity Q3 2019 · Sep 30, 2019 $217.22M
Stockholders Equity Q3 2019 · Jun 30, 2019 $231.64M
Stockholders Equity Q3 2019 · Mar 31, 2019 $248.94M
Stockholders Equity Q3 2019 · Dec 31, 2018 $266.01M
Stockholders Equity Q3 2019 · Sep 30, 2018 $280.51M
Stockholders Equity Q3 2019 · Jun 30, 2018 $294.56M
Stockholders Equity Q3 2019 · Mar 31, 2018 $307.27M
Stockholders Equity Q3 2019 · Dec 31, 2017 $324.52M
Current Liabilities Q3 2019 · Sep 30, 2019 $17.61M
Current Liabilities Q3 2019 · Dec 31, 2018 $11.83M
Total Liabilities Q3 2019 · Sep 30, 2019 $19.13M
Total Liabilities Q3 2019 · Dec 31, 2018 $11.85M
Current Assets Q3 2019 · Sep 30, 2019 $157.84M
Current Assets Q3 2019 · Dec 31, 2018 $275.38M
Total Assets Q3 2019 · Sep 30, 2019 $236.34M
Total Assets Q3 2019 · Dec 31, 2018 $277.86M
Sga Expense Q3 2019 · Sep 30, 2019 $6.06M
Sga Expense Q3 2019 · Sep 30, 2019 $16.33M
Sga Expense restated Q3 2019 · Sep 30, 2018 $4.45M
Sga Expense restated Q3 2019 · Sep 30, 2018 $17.92M
Rd Expense Q3 2019 · Sep 30, 2019 $14.99M
Rd Expense Q3 2019 · Sep 30, 2019 $45.74M
Rd Expense restated Q3 2019 · Sep 30, 2018 $12.84M
Rd Expense restated Q3 2019 · Sep 30, 2018 $37.92M
Net Income Q3 2019 · Sep 30, 2019 −$19.58M
Net Income Q3 2019 · Sep 30, 2019 −$57.97M
Net Income Q3 2019 · Jun 30, 2019 −$19.43M
Net Income Q3 2019 · Mar 31, 2019 −$18.96M
Net Income Q3 2019 · Sep 30, 2018 −$15.88M
Net Income Q3 2019 · Sep 30, 2018 −$53.67M
Net Income Q3 2019 · Jun 30, 2018 −$17.2M
Net Income Q3 2019 · Mar 31, 2018 −$20.59M
Operating Income Q3 2019 · Sep 30, 2019 −$21.05M
Operating Income Q3 2019 · Sep 30, 2019 −$62.73M
Operating Income Q3 2019 · Sep 30, 2018 −$17.36M
Operating Income Q3 2019 · Sep 30, 2018 −$57.74M
Short Term Debt Q3 2019 · Dec 31, 2018 $131K